Judge halts sales of generic Plavix
678626
A cheap generic version of blood thinner Plavix, which is used by 48 million Americans, has been blocked by a judge because of a patent dispute just three weeks after it launched.
756760
Decode Genetics Inc. said on Thursday  it was halting its late-stage clinical trial program for an  experimental oral heart attack drug after a formulation problem  with the tablets cropped up.
288359
Pfizer Inc. on Friday said a government-sponsored cancer-prevention trial of its blockbuster arthritis drug Celebrex was halted after patients taking it had more than
23469
Huge supplies of a generic form of   Bristol-Myers Squibb Co.'s BMY.N best-selling drug in the   market could hurt the company's earnings in 2006 and 2007, even   after a U.S. judge halted new shipments of the copycat drug,   analysts cautioned on Friday.
244890
A U.S. judge on Tuesday ruled that the  patent on the multibillion-dollar blood clot-preventing drug  Plavix is valid, handing a major victory to Bristol-Myers  Squibb Co.  and Sanofi-Aventis .
269196
Bristol-Myers Squibb Co.  on Monday said it had pleaded guilty to two federal criminal counts related to allegations it had illegally concealed a deal to block introduction of a generic form of its blockbuster Plavix anti-clotting drug.
137199
Alpharma Inc. said Friday that a federal court dropped an order preventing the generic drug maker from launching its version of Pfizer Inc.
354450
A U.S. judge on Thursday granted a   request from Sanofi-Aventis SASY.PA and Bristol-Myers Squibb   Co. BMY.N to block the sale of a generic form of their   top-selling Plavix blood thinner.
206852
The federal government yesterday canceled a $100 million study designed to test a new generation of drugs to prevent breast cancer in women at risk for the disease.
676044
The US Food and Drug Administration (FDA) issued a warning about the generic drug naproxen, after the National Institutes of Health (NIH) halted a clinical trial involving patients at risk of developing Alzheimers.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the
299039
South Korea's top department stores   halted sales of a popular cosmetics line famous for its skin   whiteners made by U.S. consumer products giant Procter and   Gamble PG.N, while authorities checked for potentially   harmful chemicals.
326531
Alpharma Inc. ALO.N on Friday said a  federal appellate court has set aside its earlier order that  had prevented the company from launching a generic form of  Pfizer Inc's PFE.N Neurontin capsules to treat epilepsy,  sending Alpharma shares higher.
342461
China's drug safety watchdog has suspended sales of a drug used to treat acute leukemia and rheumatoid arthritis, Xinhua news agency said on Saturday, the latest in a string of food and drug security scandals.
408832
Swiss drugmaker Roche Holding AG is taking legal action against Israel's Teva Pharmaceutical Industries Ltd  in the United States to prevent Teva from selling a generic version of Roche osteoporosis drug Boniva, Roche said on Tuesday.
44221
Novartis AG  cut its full-year results outlook as generic competition pressured sales of a key blood-pressure drug, and said U.S. regulators had delayed the approval process for an important cancer treatment.
143325
Swiss drugmaker Roche Holding AG is  taking legal action against Israel&#39;s Teva Pharmaceutical  Industries Ltd  in the United States to prevent Teva  from selling a generic version of Roche osteoporosis drug  Boniva, Roche said on Tuesday.